Pulmonic regurgitation and management challenges in the adult with tetralogy of Fallot

被引：3
作者：
Ruckdeschel E. [1 ]
Kay J.D. [1 ]
机构：
[1] University of Colorado, Denver ACHD Program, Leprino Office Building, B132, Aurora, CO 80045
来源：
Current Treatment Options in Cardiovascular Medicine | 2014年 / 16卷 / 6期
关键词：
Adult congenital heart disease; Congenital heart disease; Pulmonary valve regurgitation; Pulmonary valve replacement; Tetralogy of Fallot;
D O I：
10.1007/s11936-014-0314-5
中图分类号：
学科分类号：
摘要：
Patients with tetralogy of Fallot (TOF) are living longer than ever because of advances in surgery in childhood since the 1950s. However, surgery in childhood is not a cure and remains only a palliative procedure because almost all patients will require further intervention throughout life. The most common intervention required in adulthood is pulmonary valve replacement (PVR) because of residual pulmonary regurgitation leading to right ventricular dilation and eventual dysfunction. The most appropriate timing for PVR remains difficult to determine and is based on many factors. Our practice is to weigh not only objective factors such as right ventricular size and function but also careful objective assessment of the patient's current quality of life and functional status. © 2014 Springer Science+Business Media.
引用
收藏
相关论文
共 58 条
  • [1] Van Der Linde D., Konings E.E., Slager M.A., Et al., Birth prevalence of congenital heart disease worldwide: A systematic review and meta-analysis, J Am Coll Cardiol, 58, pp. 2241-2247, (2011)
  • [2] Bashore T.M., Adult congenital heart disease: Right ventricular outflow tract lesions, Circulation, 115, 14, pp. 1933-1947, (2007)
  • [3] Moss A.J., Allen H.D., Moss and Adams' Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adult. 7th Ed., (2008)
  • [4] Fallot A., Contribution a l'anatomie patholgique de la malldie blue (cyanosecardiaque), Marseilles Med, pp. 418-420, (1888)
  • [5] Rao B.N., Anderson R.C., Edwards J.E., Anatomic variations in the tetralogy of Fallot, Am Heart J, 81, pp. 361-371, (1971)
  • [6] Bacha E.A., Scheule A.M., Zurakowski D., Et al., Long-term results after early primary repair of tetralogy of Fallot, J Thorac Cardiovasc Surg, 122, pp. 154-161, (2001)
  • [7] Hickey E.J., Veldtman G., Bradley T.J., Et al., Late risk of outcomes for adults with repaired tetralogy of Fallot from an inception cohort spanning four decades, Eur J Cardiothorac Surg, 35, pp. 156-164, (2009)
  • [8] Wray J., Frigiola A., Bull C., Loss to specialist follow-up in congenital heart disease
  • [9] out of sight, out of mind, Heart, 99, 7, pp. 440-441, (2012)
  • [10] Mackie A.S., Rempel G.R., Rankin K.N., Nicholas D., Magill-Evans J., Risk factors for loss to follow-up among children and young adults with congenital heart disease, Cardiol Young, 22, pp. 307-315, (2012)
123456